Voyager Therapeutics Inc (VYGR) — Free Cash Flow Generation Index

Latest as of March 2024: 0.96x

Voyager Therapeutics Inc (VYGR) has a Free Cash Flow Generation Index of 0.96x as of March 2024. Free cash flow of $56.63 Million represents 1% of operating cash flow ($58.77 Million). Explore reinvestment intensity of Voyager Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.96x
Free Cash Flow / Operating CF

Free Cash Flow

$56.63 Million
USD

Operating Cash Flow

$58.77 Million
USD

Capital Expenditures

$2.14 Million
USD

Voyager Therapeutics Inc Free Cash Flow Generation Index (2015–2023)

Historical FCF Generation Index trend for Voyager Therapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see VYGR operating cash flow.

Annual Free Cash Flow Generation for Voyager Therapeutics Inc (2015–2023)

Year-by-year Free Cash Flow Generation Index for Voyager Therapeutics Inc. Check Voyager Therapeutics Inc (VYGR) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 0.96x $74.66 Million $77.92 Million $3.26 Million ▲ +13.9%
2019 0.84x $40.95 Million $48.67 Million $7.72 Million ▼ -13.7%
2015 0.98x $40.27 Million $41.30 Million $1.03 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).